CONTEXT: This retrospective analysis of an at-home monitoring system gives hope for suffers of age-related macular degeneration (AMD) | The large sale analysis of US patients showed the system could Continue Reading
CONTEXT: Publication from the analysis of the first 500 patients enrolled in a pulmonary arterial hypertension (PAH) registry showed promising treatment results in stabilising or reducing their 1-year mortality risk Continue Reading
CONTEXT: Publication of an RWE study in type 2 diabetes patients treated with SGLT2 and GLP1- receptor antagonists showing a long term reduction in risk of coronary heart disease | Continue Reading
CONTEXT: Relatively small scale RWE study (102 patients) on the variation in biomarker testing in NSCLC patients in the Netherlands. IMPACT: Low READ TIME: 1 min Quality Level Mean [1 Continue Reading
CONTEXT: Market report on the still buoyant RWE market, or at least the valuations of the market are buoyant | Different day, different figure IMPACT: Low READ TIME: 1 min Continue Reading
CONTEXT: Early days in this incredibly worth while endeavour to use the newly emerging AI/ML tools to process patient data into research grade data. Created within this cholangiocarcinoma (bile duct Continue Reading
CONTEXT: One of those quirky stories that catch our interest every now and again. Who knows where this research will lead….? IMPACT: Low READ TIME: 2 mins Quality Level Mean Continue Reading
CONTEXT: They say cancer is the great leveller. Apparently not. This is a well put together, thought-provoking article highlighting the inequalities in cancer treatments and how RWR can help even Continue Reading
CONTEXT: Commercial announcement in decentralised trials IMPACT: Low READ TIME: 1 min Quality Level Mean [1 – 10]: 5 1. “Syneos Health has signed up with siteless trial specialist Science Continue Reading
CONTEXT: Hopefully this report is not the last we will see or hear of the Pistoia Alliance. Bringing the industry together to break down barriers for data sharing on the Continue Reading
